Review



deidentified clinformatics data mart database cdm  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Optum Inc deidentified clinformatics data mart database cdm
    Deidentified Clinformatics Data Mart Database Cdm, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+clinformatics%C2%AE+data+mart+database/clinformatics+data+database+mart/pmc13157083-146-10-9
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database cdm - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study.
    Article Snippet: Data for this study were obtained from the Optum’s deidentified Clinformatics® Data Mart Database, a database of administrative health claims for members of large commercial and Medicare Advantage health plans.

    Article Title: Comorbid Depression and Anxiety Risk in Older Individuals with Geographic Atrophy: A US Claims Data Analysis.
    Article Snippet: Methods: We conducted a retrospective, noninterventional, cohort study analyzing data from three large US databases (Optum’s deidentified Clinformatics® Data Mart Database [Clinformatics®], MerativeTM MarketScan® Commercial and Medicare Databases [MarketScan], and IQVIA US PharMetrics® [PharMetrics]), employing a common data model.

    Article Title: Cardiovascular Events in Adults with Type 2 Diabetes and ASCVD Initiating Once-Weekly Semaglutide vs DPP-4is in the USA.
    Article Snippet: ASCVD, atherosclerotic cardiovascular disease; CDM, Optum’s deidentified Clinformatics® Data Mart Database, CI confidence interval, DPP-4i dipeptidyl peptidase 4 inhibitor, IP inpatient, T2D type 2 diabetes 26% lower all-cause hospitalization costs (RR 0.74 [95% CI 0.69–0.79]) and 11% lower allcause total medical costs (RR 0.89 [95% CI 0.85–0.93]; Fig. 4B).

    Article Title: Abstracts of ISPEs 2024, 40th international conference, 24-28 August 2024, Germany.
    Article Snippet: ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24– 28 August 2024S of the 2024 ISPE Annual Meeting, Berlin, Germany, 24– 28 August 2024

    Article Title: Association of Index and Changes in Fibrosis-4 Score With Outcomes in Metabolic Dysfunction-Associated Steatohepatitis
    Article Snippet: Data were obtained from the Optum deidentified Clinformatics® Data Mart Database, which is derived from administrative health claims for members of large commercial and Medicare Advantage health plans.

    Article Title: Comorbid Depression and Anxiety Risk in Older Individuals with Geographic Atrophy: A US Claims Data Analysis.
    Article Snippet: This was a retrospective, propensity scorematched, cohort study that analyzed data from three US claims datasets, Optum’s deidentified Clinformatics® Data Mart Database (Clinformatics®), MerativeTM MarketScan® Commercial and Medicare Databases (Market Scan), and IQVIA US PharMetrics® (PharMetrics), employing a common data model.

    Article Title: Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunization
    Article Snippet: This study includes data from 2 databases of commercial health care insurance claims in the United States for the years 2000 to 2022: the deidentified Clinformatics® Data Mart Database (Optum, Eden Prairie, MN) and the MarketScan Commercial Claims and Encounters Database (CCAE) (Merative, Ann Arbor, MI).

    Article Title: Modeling healthcare demands and long-term costs following pediatric traumatic brain injury
    Article Snippet: Children surviving their initial inpatient treatment for TBI were identified from Optum’s deidentified Clinformatics® Data Mart Database (2007-2018).



    Similar Products

    deidentified clinformatics data mart database cdm  (Optum Inc)
    86
    Optum Inc deidentified clinformatics data mart database cdm
    Deidentified Clinformatics Data Mart Database Cdm, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+clinformatics%C2%AE+data+mart+database/clinformatics+data+database+mart/pmc13157083-146-10-9
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database cdm - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    deidentified clinformatics data mart database  (Optum Inc)
    86
    Optum Inc deidentified clinformatics data mart database
    Deidentified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+clinformatics%C2%AE+data+mart+database/clinformatics+data+database+mart/pm41920013-2-3-2
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    deidentified clinformatics data mart database datasets  (Optum Inc)
    86
    Optum Inc deidentified clinformatics data mart database datasets
    Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum <t>Clinformatics®</t> Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.
    Deidentified Clinformatics Data Mart Database Datasets, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deidentified+clinformatics%C2%AE+data+mart+database/clinformatics+data+database+mart/pmc12718021-18-9-8
    Average 86 stars, based on 1 article reviews
    deidentified clinformatics data mart database datasets - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum Clinformatics® Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.

    Journal: The Journal of Infectious Diseases

    Article Title: Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases

    doi: 10.1093/infdis/jiaf395

    Figure Lengend Snippet: Study design. * The index date for the 1-dose and 2-dose cohorts was the date of receipt of the first and second RZV dose, respectively. The index date for unvaccinated patients corresponded to that of the vaccinated patients. Note: Propensity score matching was done at the index date. For each AID condition and sensitivity analyses, separate propensity scores and different sets of potential confounders were included. For stratified analysis with matched variables, individuals were matched on AID condition, age group, and medication category; then 1:3 matched on propensity scores with the list of covariates. Abbreviations: AID, autoimmune disease; CDM, Optum Clinformatics® Data Mart Database; HZ, herpes zoster; IR, incidence rate; non-RZV cohort, unvaccinated patients; RZV, adjuvanted recombinant zoster vaccine; RZV cohort, RZV-vaccinated patients; US, United States; VE, vaccine effectiveness; ZVL, live-attenuated varicella-zoster virus vaccine.

    Article Snippet: We conducted a retrospective matched cohort study using Optum's deidentified Clinformatics® Data Mart Database datasets from January 2018 to December 2021.

    Techniques: Recombinant, Virus